Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin. [electronic resource]
Producer: 20130228Description: 20373-8 p. digitalISSN:- 1091-6490
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Carcinogens -- metabolism
- Caspase 3 -- metabolism
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Drug Resistance, Neoplasm -- physiology
- Humans
- MAP Kinase Signaling System -- drug effects
- Melanoma -- drug therapy
- Neoplasm Proteins -- chemistry
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase Type II -- metabolism
- Nitrosation
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.